Efficacy and Safety Comparison of Tiotropium Daily + Salmeterol Daily or Twice Daily Versus Tiotropium Daily in Patients With COPD

NCT00662792 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

147

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG: Tiotropium (Tio18GEL)
DRUG: Salmeterol MDPI (Salm50DPI)
DRUG: Tiotropium (T18GEL) + Salmeterol MDPI (S_DPI)
DRUG: Tiotropium/Salmeterol (T+S_PE)

Sponsor

Boehringer Ingelheim